Lupus Erythematosus, Rheumatoid Arthritis, Type 1 Diabetes
Conditions
Brief summary
This observational study aims at finding out if individual with autoimmunity exhibit increased numbers of B cells that express two types (instead of one type) of antibodies, and if B cells of individuals genetically susceptible to autoimmunity display defects in the biological process of tolerance, which removes B cells that participate in autoimmunity.
Detailed description
Peripheral blood B cells of SLE patients are analyzed by flow cytometry to determine the frequency of B cells co-expressing immunoglobulin kappa an lambda light chains. This frequency is correlated to the disease activity.
Interventions
None listed
Sponsors
National Center for Advancing Translational Sciences (NCATS)
University of Colorado, Denver
Study design
Observational model
OTHER
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Adult Males and Females diagnosed with Lupus; * Adult Females who are pregnant and diagnosed with: * lupus erythematosus * rheumatoid arthritis, or * type 1 diabetes.
Exclusion criteria
* Adult males or adult females treated with B-cell depletion therapies.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Frequency of kappa to lambda ratios of B cells in blood of autoimmune adults | 1 day | For peripheral adult blood, the main outcome measure is the frequency of κ/λ (kappa to lambda ratios) dual immunoglobulin B cells within the overall B (CD19+ or CD20+) cell population. The collected data will be aggregated as the average frequency of κ/λ B cells in subjects with autoimmunity relative to healthy controls. |
| Frequency of CD19 and IgM low B cells in cord blood of babies born from autoimmune mothers | 1 day | For cord blood samples, the main outcome measurement is the frequency of B cells that express both low levels of CD19 and IgM within the total (CD19+ or CD20+) B cell population. The collected data will be aggregated as the average frequency of CD19low/IgMlow B cells in subjects that were born from autoimmune mothers relative to those born from healthy mothers. Moreover, data will also be stratified in respect to the presence or absence of the PTPN22-R620W allele, which is a risk allele for autoimmunity. |
Countries
United States
Outcome results
None listed